1 Subjects: “...Clinical Trials as Topic...”

2 Subjects: “...Randomized Controlled Trials as Topic...”

3 Subjects: “...Clinical Trials as Topic...”

4 Subjects: “...Clinical Trials as Topic...”

5 “... SOE). One head-to-head trial comparing exenatide with liraglutide reported a slightly greater...”

6 “... SOE). One head-to-head trial comparing exenatide with liraglutide reported a slightly greater...”

7 “... trials support greater efficacy with the addition of a LABA to an ICS than with a higher dose ICS (high...”

8 “... trials support greater efficacy with the addition of a LABA to an ICS than with a higher dose ICS (high...”

9 Subjects: “...Clinical Trials as Topic...”

10 Subjects: “...Clinical Trials as Topic...”

11 “... SC (Rebif(r)) or interferon beta-1b (Betaseron(r)) based on 2 head-to-head trials. Evidence...”

12 “... SC (Rebif(r)) or interferon beta-1b (Betaseron(r)) based on 2 head-to-head trials. Evidence...”

13 “...RESULTS AND CONCLUSIONS: Although we identified 10 head-to-head trials comparing 2 or more long...”

14 “...RESULTS AND CONCLUSIONS: Although we identified 10 head-to-head trials comparing 2 or more long...”

15 “.... DATA SOURCES: To identify published studies, we searched MEDLINE, Cochrane Central Register...”

16 “... on three head-to-head trials, several large observational studies, and indirect comparisons of placebo...”

17 “...), and the Cochrane Central Register of Controlled Trials(r) and Database of Abstracts of Reviews of Effects through...”

18 “... on three head-to-head trials, several large observational studies, and indirect comparisons of placebo...”

19 “...), and the Cochrane Central Register of Controlled Trials(r) and Database of Abstracts of Reviews of Effects through...”

20